Cervical Cancer Diagnostic Testing Market Biggest Revenue Growth US$ 7,165.92 million by 2028 in World

The Cervical Cancer Diagnostic Testing Market is projected to reach US$ 7,165.92 million by 2028 from US$ 5,141.25 million in 2021; it is expected to grow at a CAGR of 4.9% from 2021 to 2028.

Cervical cancer has a significant mortality rate (almost 50%), which can be lowered with early detection and prevention. Precancerous alterations offer opportunities for prevention and treatment because disease progression is often delayed. However, due to a lack of awareness or access to diagnostic services, many cases are detected at later stages of illness progression. Human Papillomavirus (HPV) is a primary cause of cervical cancer that is typically transmitted through sexual contact. There are over 100 HPV strains, and 13 of which are high-risk or carcinogenic. The active gene - E6 or E7 - determines whether an HPV strain is high or low risk. E6 binds to p53, causing proteolytic destruction. E7, on the other hand, binds to retinoblastoma; the binding displaces previously attached transcription factors, resulting in the cell cycle being stopped and apoptosis regulation being inhibited. The HPV test detects human papillomavirus in cervical cells. Other screening approaches employed in low-resource areas of developing countries are HPV DNA testing and visual inspection.

Get Sample Copy of this Report@
https://www.theinsightpartners.com/sample/TIPRE00016639/?utm_source=OpenPR&utm_medium=10411

Top Key Players:
• F. Hoffmann-La Roche Ltd.
• Abbott
• Quest Diagnostics Incorporated
• QIAGEN
• Hologic, Inc.
• DYSIS Medical Inc.
• Femasys Inc.
• Guided Therapeutics, Inc.
• Cooper Companies, Inc.
• BD

Cervical Cancer Diagnostic Testing Market – Segmentation
The cervical cancer diagnostic testing market is segmented on the basis of type, and service provider. Based on type, the market is sub-segmented into PAP testing, HPV testing, colposcopy, cervical biopsies, cystoscopy, and others. Based on the service provider, the market is further segmented into diagnostics and research laboratories, hospitals and clinics, specialty clinics, and home care services.

Market Insights
Increasing Prevalence of Cancer to Drive Cervical Cancer Diagnostic Testing Market Growth During Forecast Period:
Cancer has emerged as a leading cause of death across the world. According to the World Health Organization (WHO), cancer was the first leading cause of death in the people of below 70 years in 183 countries and fourth leading cause of death in 123 countries worldwide in 2019. In addition, according to data published by the WHO in March 2021, ~10 million deaths occurred in 2020 due to different cancer types. The rising incidence of cervical cancer among women worldwide drives the cervical cancer diagnostic testing market growth. According to the WHO, more than 270,000 deaths of women are recorded due to cervical cancer each year. Cervical cancer mortality rates are greater in low-income countries due to the late diagnosis of the disease. The market is predicted to grow in the coming years due to the increasing acceptance of cervical cancer diagnostic tests for the early detection of the disease.

The Covid-19 (coronavirus) pandemic is impacting society and the overall economy across the world. The impact of this pandemic is growing day by day as well as affecting the supply chain. The COVID-19 crisis is creating uncertainty in the stock market, massive slowing of supply chain, falling business confidence, and increasing panic among the customer segments. The overall effect of the pandemic is impacting the production process of several industries. This report on ‘CERVICAL CANCER DIAGNOSTIC TESTING Market’ provides the analysis on impact on Covid-19 on various business segments and country markets. The reports also showcase market trends and forecast to 2028, factoring the impact of Covid -19 Situation.

ASSESING THE COVID-19 IMPACT on Cervical Cancer Diagnostic Testing Market? Visit Here for PDF Copy >>
https://www.theinsightpartners.com/covid-analysis-sample/TIPRE00016639/?utm_source=OpenPR&utm_medium=10411

The geographical segmentation has been done across global regions such as North America, Latin America, Asia-Pacific, Africa, and Europe on the basis of productivity. It throws light on recent advancements in technologies and certain methodologies which will help for boosting the outcome of the businesses. Furthermore, it offers detailed data of cost structure such as the cost of manpower, tools, technologies, and cost of raw material. It is a complete source of analytical information of different verticals of businesses such as type, size, applications, and end-users.

Driving and restraining factors are impacting the progress of Cervical Cancer Diagnostic Testing market are also analyzed in the research report. The current competitive scenario has been elaborated by examining the market situations of global as well as domestic market. Finally, it throws light on manufacturers or service providers for a better understanding of the market.

Purchase a copy of the report @
https://www.theinsightpartners.com/buy/TIPRE00016639/?utm_source=OpenPR&utm_medium=10411

Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.

This release was published on openPR.